Chun-Jen Lin,Guang Peng,Shiaw-Yih Lin,Gordon B. Mills
申请号：
US14772549
公开号：
US09850542B2
申请日:
2014.03.04
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Methods for identifying and treating cancers that are homologous recombination (HR)-repair defective. In some aspects, HR defective cancers are treated with a PARP inhibitor therapy. Methods for sensitizing cancers to a PARP inhibitor therapy are also provided.
